$CCXI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ChemoCentryx, Inc.. Get notifications about new insider transactions in ChemoCentryx, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 49.50 | 3,000 | 148,510 | 94,180 | 97.2 K to 94.2 K (-3.09 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 10.86 | 2,800 | 30,408 | 97,180 | 94.4 K to 97.2 K (+2.97 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 8.19 | 200 | 1,638 | 94,380 | 94.2 K to 94.4 K (+0.21 %) |
Feb 13 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Sell | S | 49.15 | 18,941 | 930,888 | 493 | 19.4 K to 493 (-97.46 %) |
Feb 10 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 8.19 | 36,850 | 301,802 | 42,901 | |
Feb 10 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 47.31 | 36,850 | 1,743,340 | 76,247 | 113.1 K to 76.2 K (-32.58 %) |
Feb 10 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 8.19 | 36,850 | 301,802 | 113,097 | 76.2 K to 113.1 K (+48.33 %) |
Feb 06 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 14.31 | 119,525 | 1,710,403 | 365,563 | |
Feb 06 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 45.18 | 119,525 | 5,400,701 | 2,268,557 | 2.4 M to 2.3 M (-5.01 %) |
Feb 06 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 14.31 | 119,525 | 1,710,403 | 2,388,082 | 2.3 M to 2.4 M (+5.27 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 14.31 | 99,617 | 1,425,519 | 0 | |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 14.31 | 3,837 | 54,907 | 99,617 | |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 45.10 | 99,617 | 4,492,229 | 94,180 | 193.8 K to 94.2 K (-51.40 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 14.31 | 99,617 | 1,425,519 | 193,797 | 94.2 K to 193.8 K (+105.77 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 44.91 | 3,837 | 172,317 | 94,180 | 98 K to 94.2 K (-3.91 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 14.31 | 3,837 | 54,907 | 98,017 | 94.2 K to 98 K (+4.07 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 8.19 | 13,150 | 107,699 | 79,751 | |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 8.19 | 48,471 | 396,977 | 92,901 | |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 47.03 | 13,150 | 618,451 | 76,427 | 89.6 K to 76.4 K (-14.68 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 8.19 | 13,150 | 107,699 | 89,397 | 76.2 K to 89.4 K (+17.25 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 44.47 | 48,471 | 2,155,525 | 76,247 | 124.7 K to 76.2 K (-38.86 %) |
Feb 05 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 8.19 | 48,471 | 396,977 | 124,718 | 76.2 K to 124.7 K (+63.57 %) |
Jan 23 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 8.19 | 1,259 | 10,311 | 141,372 | |
Jan 23 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 44.00 | 1,259 | 55,392 | 76,247 | 77.5 K to 76.2 K (-1.62 %) |
Jan 23 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 8.19 | 1,259 | 10,311 | 77,506 | 76.2 K to 77.5 K (+1.65 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 10.27 | 105,735 | 1,085,898 | 38,948 | |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 10.27 | 30,317 | 311,356 | 144,683 | |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 42.13 | 22,179 | 934,399 | 2,268,557 | 2.3 M to 2.3 M (-0.97 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 41.46 | 83,556 | 3,463,872 | 2,290,736 | 2.4 M to 2.3 M (-3.52 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 10.27 | 105,735 | 1,085,898 | 2,374,292 | 2.3 M to 2.4 M (+4.66 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 41.01 | 30,317 | 1,243,170 | 2,268,557 | 2.3 M to 2.3 M (-1.32 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 10.27 | 30,317 | 311,356 | 2,298,874 | 2.3 M to 2.3 M (+1.34 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 14.28 | 15,737 | 224,724 | 0 | |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 14.28 | 47,261 | 674,887 | 15,737 | |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 41.03 | 15,737 | 645,730 | 94,180 | 109.9 K to 94.2 K (-14.32 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 14.28 | 15,737 | 224,724 | 109,917 | 94.2 K to 109.9 K (+16.71 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 40.99 | 47,261 | 1,937,101 | 94,180 | 141.4 K to 94.2 K (-33.41 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 14.28 | 47,261 | 674,887 | 141,441 | 94.2 K to 141.4 K (+50.18 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 7.10 | 50,000 | 355,000 | 0 | |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 40.07 | 50,000 | 2,003,480 | 76,247 | 126.2 K to 76.2 K (-39.60 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 7.10 | 50,000 | 355,000 | 126,247 | 76.2 K to 126.2 K (+65.58 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 11.02 | 13,500 | 148,770 | 40,500 | |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 10.86 | 31,959 | 347,075 | 34,741 | |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 6.62 | 29,166 | 193,079 | 10,834 | |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 3.57 | 14,554 | 51,958 | 834 | |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Sell | S | 40.20 | 32,878 | 1,321,719 | 19,434 | 52.3 K to 19.4 K (-62.85 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Sell | S | 39.74 | 56,301 | 2,237,497 | 52,312 | 108.6 K to 52.3 K (-51.84 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 11.02 | 13,500 | 148,770 | 108,613 | 95.1 K to 108.6 K (+14.19 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 10.86 | 31,959 | 347,075 | 95,113 | 63.2 K to 95.1 K (+50.60 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 6.62 | 29,166 | 193,079 | 63,154 | 34 K to 63.2 K (+85.81 %) |
Jan 17 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 3.57 | 14,554 | 51,958 | 33,988 | 19.4 K to 34 K (+74.89 %) |
Jan 15 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 7.10 | 30,145 | 214,030 | 50,000 | |
Jan 15 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 7.10 | 86,311 | 612,808 | 80,145 | |
Jan 15 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 37.78 | 30,145 | 1,138,908 | 76,247 | 106.4 K to 76.2 K (-28.33 %) |
Jan 15 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 7.10 | 30,145 | 214,030 | 106,392 | 76.2 K to 106.4 K (+39.54 %) |
Jan 15 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 37.48 | 42,755 | 1,602,581 | 76,247 | 119 K to 76.2 K (-35.93 %) |
Jan 15 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 36.71 | 43,556 | 1,598,958 | 119,002 | 162.6 K to 119 K (-26.79 %) |
Jan 15 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 7.10 | 86,311 | 612,808 | 162,558 | 76.2 K to 162.6 K (+113.20 %) |
Jan 15 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Sell | S | 37.44 | 14,715 | 550,916 | 5,345 | 20.1 K to 5.3 K (-73.35 %) |
Jan 15 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Sell | S | 36.69 | 15,285 | 560,770 | 20,060 | 35.3 K to 20.1 K (-43.25 %) |
Jan 14 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 3.57 | 1,000 | 3,570 | 15,388 | |
Jan 14 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Sell | S | 39.02 | 1,000 | 39,017 | 19,434 | 20.4 K to 19.4 K (-4.89 %) |
Jan 14 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 3.57 | 1,000 | 3,570 | 20,434 | 19.4 K to 20.4 K (+5.15 %) |
Jan 08 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 3.57 | 23,612 | 84,295 | 16,388 | |
Jan 08 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 8.19 | 37,300 | 305,487 | 0 | |
Jan 08 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 6.08 | 30,000 | 182,400 | 0 | |
Jan 08 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 14.28 | 7,000 | 99,960 | 0 | |
Jan 08 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Option Exercise | M | 10.94 | 25,000 | 273,500 | 0 | |
Jan 08 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Sell | S | 34.83 | 49,956 | 1,739,803 | 19,434 | 69.4 K to 19.4 K (-71.99 %) |
Jan 08 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Sell | S | 34.39 | 72,956 | 2,509,205 | 69,390 | 142.3 K to 69.4 K (-51.25 %) |
Jan 08 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 3.57 | 23,612 | 84,295 | 142,346 | 118.7 K to 142.3 K (+19.89 %) |
Jan 08 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 8.19 | 37,300 | 305,487 | 118,734 | 81.4 K to 118.7 K (+45.80 %) |
Jan 08 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 6.08 | 30,000 | 182,400 | 81,434 | 51.4 K to 81.4 K (+58.33 %) |
Jan 08 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 14.28 | 7,000 | 99,960 | 51,434 | 44.4 K to 51.4 K (+15.75 %) |
Jan 08 2020 | CCXI | ChemoCentryx, Inc. | Kwan Pui San | Principal Acctg Off ... | Buy | M | 10.94 | 25,000 | 273,500 | 44,434 | 19.4 K to 44.4 K (+128.64 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 23,333 | 0 | 46,667 | |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 30,000 | |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 33,334 | 0 | 0 | |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Payment of Exercise | F | 39.55 | 46,965 | 1,857,466 | 2,268,557 | 2.3 M to 2.3 M (-2.03 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 23,333 | 0 | 2,315,522 | 2.3 M to 2.3 M (+1.02 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 30,000 | 0 | 2,292,189 | 2.3 M to 2.3 M (+1.33 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 33,334 | 0 | 2,262,189 | 2.2 M to 2.3 M (+1.50 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 10,000 | 0 | 20,000 | |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 13,334 | 0 | 0 | |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Payment of Exercise | F | 39.55 | 18,173 | 718,742 | 94,180 | 112.4 K to 94.2 K (-16.17 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 10,000 | 0 | 112,353 | 102.4 K to 112.4 K (+9.77 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 10,000 | 0 | 102,353 | 92.4 K to 102.4 K (+10.83 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 13,334 | 0 | 92,353 | 79 K to 92.4 K (+16.87 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 6,666 | 0 | 13,334 | |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 6,667 | 0 | 6,667 | |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Payment of Exercise | F | 39.55 | 12,786 | 505,686 | 76,247 | 89 K to 76.2 K (-14.36 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 6,666 | 0 | 89,033 | 82.4 K to 89 K (+8.09 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 6,667 | 0 | 82,367 | 75.7 K to 82.4 K (+8.81 %) |
Jan 03 2020 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 10,000 | 0 | 75,700 | 65.7 K to 75.7 K (+15.22 %) |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 3.57 | 15,178 | 54,185 | 91,785 | |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 8.19 | 12,868 | 105,389 | 192,132 | |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 7.10 | 4,169 | 29,600 | 0 | |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 14.28 | 7,002 | 99,989 | 62,998 | |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 14.31 | 17,712 | 253,459 | 103,454 | |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 10.27 | 22,090 | 226,864 | 0 | |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 3.57 | 15,178 | 54,185 | 79,019 | 63.8 K to 79 K (+23.77 %) |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 8.19 | 12,868 | 105,389 | 63,841 | 51 K to 63.8 K (+25.24 %) |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 7.10 | 4,169 | 29,600 | 50,973 | 46.8 K to 51 K (+8.91 %) |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 14.28 | 7,002 | 99,989 | 46,804 | 39.8 K to 46.8 K (+17.59 %) |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 14.31 | 17,712 | 253,459 | 39,802 | 22.1 K to 39.8 K (+80.18 %) |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 10.27 | 22,090 | 226,864 | 22,090 | 0 to 22.1 K |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 3.57 | 15,178 | 54,185 | 91,785 | |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 8.19 | 12,868 | 105,389 | 192,132 | |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 7.10 | 4,169 | 29,600 | 0 | |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 14.28 | 7,002 | 99,989 | 62,998 | |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 14.31 | 17,712 | 253,459 | 103,454 | |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 10.27 | 22,090 | 226,864 | 0 | |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 3.57 | 15,178 | 54,185 | 79,019 | 63.8 K to 79 K (+23.77 %) |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 8.19 | 12,868 | 105,389 | 63,841 | 51 K to 63.8 K (+25.24 %) |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 7.10 | 4,169 | 29,600 | 50,973 | 46.8 K to 51 K (+8.91 %) |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 14.28 | 7,002 | 99,989 | 46,804 | 39.8 K to 46.8 K (+17.59 %) |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 14.31 | 17,712 | 253,459 | 39,802 | 22.1 K to 39.8 K (+80.18 %) |
Dec 30 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 10.27 | 22,090 | 226,864 | 22,090 | 0 to 22.1 K |
Dec 23 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.62 | 2,346 | 15,531 | 87,654 | |
Dec 23 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 3.57 | 12,000 | 42,840 | 53,000 | |
Dec 23 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 8.19 | 12,369 | 101,302 | 142,631 | |
Dec 23 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 7.10 | 3,544 | 25,162 | 166,456 | |
Dec 23 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.62 | 2,346 | 15,531 | 65,700 | 63.4 K to 65.7 K (+3.70 %) |
Dec 23 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 3.57 | 12,000 | 42,840 | 63,354 | 51.4 K to 63.4 K (+23.37 %) |
Dec 23 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 8.19 | 12,369 | 101,302 | 51,354 | 39 K to 51.4 K (+31.73 %) |
Dec 23 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 7.10 | 3,544 | 25,162 | 38,985 | 35.4 K to 39 K (+10.00 %) |
Dec 04 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | M | 6.00 | 31,990 | 191,940 | 0 | |
Dec 04 2019 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | M | 6.00 | 31,990 | 191,940 | 104,189 | 72.2 K to 104.2 K (+44.31 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.30 | 279,166 | 1,758,746 | 0 | |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 35.60 | 1,500 | 53,393 | 2,228,855 | 2.2 M to 2.2 M (-0.07 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 34.69 | 54,936 | 1,905,477 | 2,230,355 | 2.3 M to 2.2 M (-2.40 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 33.86 | 29,290 | 991,633 | 2,285,291 | 2.3 M to 2.3 M (-1.27 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 32.65 | 14,969 | 488,726 | 2,314,581 | 2.3 M to 2.3 M (-0.64 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 31.76 | 32,780 | 1,041,076 | 2,329,550 | 2.4 M to 2.3 M (-1.39 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 30.79 | 78,581 | 2,419,116 | 2,362,330 | 2.4 M to 2.4 M (-3.22 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 29.23 | 31,335 | 915,869 | 2,440,911 | 2.5 M to 2.4 M (-1.27 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 28.44 | 14,134 | 401,955 | 2,472,246 | 2.5 M to 2.5 M (-0.57 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 27.30 | 21,641 | 590,866 | 2,486,380 | 2.5 M to 2.5 M (-0.86 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.30 | 279,166 | 1,758,746 | 2,508,021 | 2.2 M to 2.5 M (+12.53 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 7.10 | 195,831 | 1,390,400 | 4,169 | |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 6.90 | 44,180 | 304,842 | 0 | |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 6.30 | 71,614 | 451,168 | 0 | |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 35.99 | 1,000 | 35,993 | 91,317 | 92.3 K to 91.3 K (-1.08 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 34.68 | 53,691 | 1,862,004 | 92,317 | 146 K to 92.3 K (-36.77 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 33.89 | 38,894 | 1,318,032 | 146,008 | 184.9 K to 146 K (-21.03 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 32.65 | 16,408 | 535,761 | 184,902 | 201.3 K to 184.9 K (-8.15 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 31.76 | 38,305 | 1,216,567 | 201,310 | 239.6 K to 201.3 K (-15.99 %) |
Nov 27 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 30.78 | 87,776 | 2,701,789 | 239,615 | 327.4 K to 239.6 K (-26.81 %) |